EPSA: A novel supercritical fluid chromatography technique enabling the design of permeable cyclic peptides

ACS Medicinal Chemistry Letters

Volumn 5, Issue 10, 2014, Pages 1167-1172

  Goetz, Gilles H ^a   Philippe, Laurence ^a   Shapiro, Michael J ^a  

^a PFIZER INC   (United States)

Author keywords

cyclic peptides; EPSA; intramolecular hydrogen bonding; permeability; polarity

Indexed keywords

CYCLOPEPTIDE;

ARTICLE; CALIBRATION; EPSA; HYDROGEN BOND; LIPOPHILICITY; MEDICINAL CHEMISTRY; MOLECULAR WEIGHT; PERMEABILITY; SUPERCRITICAL FLUID CHROMATOGRAPHY;

EID: 84907903034     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml500239m     Document Type: Article

References (26)

1. Craik, D. J.; Fairlie, D. P.; Liras, S.; Price, D. The Future of Peptide-Based Drugs Chem. Biol. Drug Des. 2013, 81, 136-147
2. Woodley, J. F. Enzymatic Barriers for GI Peptide and Protein Delivery Crit. Rev. Ther. Drug Carrier Syst. 1994, 11, 61-95
3. Salamat-Miller, N.; Johnston, T. P. Current Strategies Used to Enhance the Paracellular Transport of Therapeutic Polypeptides across the Intestinal Epithelium Int. J. Pharm. 2005, 294, 201-216
4. Bock, J. E.; Gavenonis, J.; Kritzer, J. A. Getting in Shape: Controlling Peptide Bioactivity and Bioavailability Using Conformational Constraints ACS Chem. Biol. 2012, 8, 488-499
5. Chatterjee, J.; Gilon, C.; Hoffman, A.; Kessler, H. N-Methylation of Peptides: A New Perspective in Medicinal Chemistry Acc. Chem. Res. 2008, 41, 1331-1342
6. Hess, S.; Ovadia, O.; Shalev, D. E.; Senderovich, H.; Qadri, B.; Yehezkel, T.; Salitra, Y.; Sheynis, T.; Jelinek, R.; Gilon, C.; Hoffman, A. Effect of Structural and Conformation Modifications, Including Backbone Cyclization, of Hydrophilic Hexapeptides on Their Intestinal Permeability and Enzymatic Stability J. Med. Chem. 2007, 50, 6201-6211
7. Hess, S.; Linde, Y.; Ovadia, O.; Safrai, E.; Shalev, D. E.; Swed, A.; Halbfinger, E.; Lapidot, T.; Winkler, I.; Gabinet, Y.; Faier, A.; Yarden, D.; Xiang, Z.; Portillo, F. P.; Haskell-Luevano, C.; Gilon, C.; Hoffman, A. Backbone Cyclic Peptidomimetic Melanocortin-4 Receptor Agonist as a Novel Orally Administrated Drug Lead for Treating Obesity J. Med. Chem. 2008, 51, 1026-1034
8. Rezai, T.; Bock, J. E.; Zhou, M. V.; Kalyanaraman, C.; Lokey, R. S.; Jacobson, M. P. Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides J. Am. Chem. Soc. 2006, 128, 14073-14080
9. Rezai, T.; Yu, B.; Millhauser, G.; Jacobson, M. P.; Lokey, R. S. Testing the Conformational Hypothesis of Passive Membrane Permeability Using Synthetic Cyclic Peptide Diastereomers J. Am. Chem. Soc. 2006, 128, 2510-2511
10. Alex, A.; Millan, D. S.; Perez, M.; Wakenhut, F.; Whitlock, G. A. Intramolecular Hydrogen Bonding to Improve Membrane Permeability and Absorption in Beyond Rule of Five Chemical Space Med. Chem. Commun. 2011, 2, 669-674
11. Ovadia, O.; Greenberg, S.; Chatterjee, J.; Laufer, B.; Opperer, F.; Kessler, H.; Gilon, C.; Hoffman, A. The Effect of Multiple N-Methylation on Intestinal Permeability of Cyclic Hexapeptides Mol. Pharm. 2011, 8, 479-487
12. Beck, J. G.; Chatterjee, J.; Laufer, B.; Kiran, M. U.; Frank, A. O.; Neubauer, S.; Ovadia, O.; Greenberg, S.; Gilon, C.; Hoffman, A.; Kessler, H. Intestinal Permeability of Cyclic Peptides: Common Key Backbone Motifs Identified J. Am. Chem. Soc. 2012, 134, 12125-12133
13. Biron, E.; Chatterjee, J.; Ovadia, O.; Langenegger, D.; Brueggen, J.; Hoyer, D.; Schmid, H. A.; Jelinek, R.; Gilon, C.; Hoffman, A.; Kessler, H. Improving Oral Bioavailability of Peptides by Multiple N-Methylation: Somatostatin Analogues Angew. Chem. 2008, 47, 2595-2599
14. White, T. R.; Renzelman, C. M.; Rand, A. C.; Rezai, T.; McEwen, C. M.; Gelev, V. M.; Turner, R. A.; Linington, R. G.; Leung, S. S.; Kalgutkar, A. S.; Bauman, J. N.; Zhang, Y.; Liras, S.; Price, D. A.; Mathiowetz, A. M.; Jacobson, M. P.; Lokey, R. S. On-Resin N-Methylation of Cyclic Peptides for Discovery of Orally Bioavailable Scaffolds Nat. Chem. Biol. 2011, 7, 810-817
15. Artursson, P. Epithelial Transport of Drugs in Cell Culture. I: A Model for Studying the Passive Diffusion of Drugs over Intestinal Absorbtive (Caco-2) Cells. J. Pharm. Sci. 1990, 79.
16. Artursson, P.; Magnusson, C. Epithelial Transport of Drugs in Cell Culture. II: Effect of Extracellular Calcium Concentration on the Paracellular Transport of Drugs of Different Lipophilicities across Monolayers of Intestinal Epithelial (Caco-2) Cells J. Pharm. Sci. 1990, 79, 595-600
17. Di, L.; Whitney-Pickett, C.; Umland, J. P.; Zhang, H.; Zhang, X.; Gebhard, D. F.; Lai, Y.; F, J. J., III; Davidson, R. E.; Smith, R.; Reyner, E. L.; Lee, C.; Feng, B.; Rotter, C.; Varma, M. V.; Kempshall, S.; Fenner, K.; El-kattan, A. F.; Liston, T. E.; Troutman, M. D. Development of a New Permeability Assay Using Low-Efflux MDCKII Cells J. Pharm. Sci. 2011, 100, 4974-4985
18. Avdeef, A. The Rise of PAMPA Expert Opin. Drug Metab. Toxicol. 2005, 1, 325-342
19. Avdeef, A.; Artursson, P.; Neuhoff, S.; Lazorova, L.; Gråsjö, J.; Tavelin, S. Caco-2 Permeability of Weakly Basic Drugs Predicted with the Double-Sink PAMPA Pka(Flux) Method Eur. J. Pharm. Sci. 2005, 24, 333-349
20. Guimarães, C. R. W.; Mathiowetz, A. M.; Shalaeva, M.; Goetz, G.; Liras, S. Use of 3d Properties to Characterize Beyond Rule-of-5 Property Space for Passive Permeation J. Chem. Inf. Model. 2012, 52, 882-890
21. Goetz, G. H.; Farrell, W.; Shalaeva, M.; Sciabola, S.; Anderson, D.; Yan, J.; Philippe, L.; Shapiro, M. J. High Throughput Method for the Indirect Detection of Intramolecular Hydrogen Bonding J. Med. Chem. 2014, 57, 2920-2929
22. Lombardo, F.; Shalaeva, M. Y.; Tupper, K. A.; Gao, F.; Abraham, M. H. Elogpoct: A Tool for Lipophilicity Determination in Drug Discovery J. Med. Chem. 2000, 43, 2922-2928
23. Lombardo, F.; Shalaeva, M. Y.; Tupper, K. A.; Gao, F. Elogdoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds J. Med. Chem. 2001, 44, 2490-2497
24. Cheng, H.; Hoffman, J. E.; Le, P. T.; Pairish, M.; Kania, R.; Farrell, W.; Bagrodia, S.; Yuan, J.; Sun, S.; Zhang, E.; Xiang, C.; Dalvie, D.; Rahavendran, S. V. Structure-Based Design, SAR Analysis and Antitumor Activity of PI3K/mTOR Dual Inhibitors from 4-Methyl-pyridopyrimidinone Series Biorg. Med. Chem. Lett. 2013, 23, 2787-2792
25. Wakenhut, F.; Tran, T. D.; Pickford, C.; Shaw, S.; Westby, M.; Smith-Burchnell, C.; Watson, L.; Paradowski, M.; Milbank, Jared; Stonehouse, D.; Cheung, K.; Wybrow, R.; Daverio, F.; Crook, S.; Statham, K.; Leese, D.; Stead, D.; Adam, F.; Hay, D.; Roberts, L. R.; Chiva, J.-Y.; Nichols, C.; Blakemore, D. C.; Goetz, G. H.; Che, Y.; Gardner, I.; Dayal, S.; Pike, A.; Webster, R.; Pryde, D. C. The Discovery of Potent NS5A Inhibitors with a Unique Resistance Profile-Part 2 ChemMedChem 2014, 9, 1387-1396
26. Rand A.C.. Leung S.S.F.; Eng H., Rotter C.J., Sharma R., Kalgutkar A.S., Zhang Y., Varma M.V., Farley K.A., Khunte B., Limberakis C., Price D.A., Liras S., Mathiowetz A.M., Jacobson M.P., Lokey R.S., Optimizing PK Properties of Cyclic Peptides: The Effect of Side Chain Substitutions on Permeability and Clearance, Med. Chem. Commun.,1282-1289, 2012, 3.